Focus: AiM Medical Robotics develops MRI-compatible intraoperative robotic systems for minimally invasive procedures across ophthalmology, gastroenterology, metabolic diseases, and neurology. The company is early-stage, Series A–funded, and focused on a high-barrier medical device segment.
Profile data last refreshed 10h ago · AI intelligence enriched 2w ago
Growing — net +15 jobs in 30d
16 jobs added vs 1 removed. Steady team buildout.
Strong fit for early-career software/robotics engineers and technical innovators willing to bet on an unproven but high-reward medical device thesis; higher risk for those seeking stability or near-term commercial traction.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for AiM Medical Robotics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from AiM Medical Robotics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Based on last 4 crawl cycles
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo